Cargando…
Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071112/ https://www.ncbi.nlm.nih.gov/pubmed/36384251 http://dx.doi.org/10.3324/haematol.2022.281954 |
_version_ | 1785019133242376192 |
---|---|
author | Jallouk, Andrew P. Gouni, Sushanth Westin, Jason Feng, Lei Mistry, Haleigh Steiner, Raphael E. James, Jinsu Noorani, Mansoor Horowitz, Sandra Puebla-Osorio, Nahum Fayad, Luis E. Iyer, Swaminathan P. Hawkins, Misha Flowers, Christopher R. Ahmed, Sairah Nastoupil, Lo retta J Kebriaei, Partow Shpall, Elizabeth J. Neelapu, Sattva S. Nieto, Yago Strati, Paolo |
author_facet | Jallouk, Andrew P. Gouni, Sushanth Westin, Jason Feng, Lei Mistry, Haleigh Steiner, Raphael E. James, Jinsu Noorani, Mansoor Horowitz, Sandra Puebla-Osorio, Nahum Fayad, Luis E. Iyer, Swaminathan P. Hawkins, Misha Flowers, Christopher R. Ahmed, Sairah Nastoupil, Lo retta J Kebriaei, Partow Shpall, Elizabeth J. Neelapu, Sattva S. Nieto, Yago Strati, Paolo |
author_sort | Jallouk, Andrew P. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10071112 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Fondazione Ferrata Storti |
record_format | MEDLINE/PubMed |
spelling | pubmed-100711122023-04-05 Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response Jallouk, Andrew P. Gouni, Sushanth Westin, Jason Feng, Lei Mistry, Haleigh Steiner, Raphael E. James, Jinsu Noorani, Mansoor Horowitz, Sandra Puebla-Osorio, Nahum Fayad, Luis E. Iyer, Swaminathan P. Hawkins, Misha Flowers, Christopher R. Ahmed, Sairah Nastoupil, Lo retta J Kebriaei, Partow Shpall, Elizabeth J. Neelapu, Sattva S. Nieto, Yago Strati, Paolo Haematologica Letter to the Editor Fondazione Ferrata Storti 2022-11-17 /pmc/articles/PMC10071112/ /pubmed/36384251 http://dx.doi.org/10.3324/haematol.2022.281954 Text en Copyright© 2023 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Letter to the Editor Jallouk, Andrew P. Gouni, Sushanth Westin, Jason Feng, Lei Mistry, Haleigh Steiner, Raphael E. James, Jinsu Noorani, Mansoor Horowitz, Sandra Puebla-Osorio, Nahum Fayad, Luis E. Iyer, Swaminathan P. Hawkins, Misha Flowers, Christopher R. Ahmed, Sairah Nastoupil, Lo retta J Kebriaei, Partow Shpall, Elizabeth J. Neelapu, Sattva S. Nieto, Yago Strati, Paolo Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response |
title | Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response |
title_full | Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response |
title_fullStr | Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response |
title_full_unstemmed | Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response |
title_short | Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response |
title_sort | axicabtagene ciloleucel in relapsed or refractory large b-cell lymphoma patients in complete metabolic response |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071112/ https://www.ncbi.nlm.nih.gov/pubmed/36384251 http://dx.doi.org/10.3324/haematol.2022.281954 |
work_keys_str_mv | AT jalloukandrewp axicabtageneciloleucelinrelapsedorrefractorylargebcelllymphomapatientsincompletemetabolicresponse AT gounisushanth axicabtageneciloleucelinrelapsedorrefractorylargebcelllymphomapatientsincompletemetabolicresponse AT westinjason axicabtageneciloleucelinrelapsedorrefractorylargebcelllymphomapatientsincompletemetabolicresponse AT fenglei axicabtageneciloleucelinrelapsedorrefractorylargebcelllymphomapatientsincompletemetabolicresponse AT mistryhaleigh axicabtageneciloleucelinrelapsedorrefractorylargebcelllymphomapatientsincompletemetabolicresponse AT steinerraphaele axicabtageneciloleucelinrelapsedorrefractorylargebcelllymphomapatientsincompletemetabolicresponse AT jamesjinsu axicabtageneciloleucelinrelapsedorrefractorylargebcelllymphomapatientsincompletemetabolicresponse AT nooranimansoor axicabtageneciloleucelinrelapsedorrefractorylargebcelllymphomapatientsincompletemetabolicresponse AT horowitzsandra axicabtageneciloleucelinrelapsedorrefractorylargebcelllymphomapatientsincompletemetabolicresponse AT pueblaosorionahum axicabtageneciloleucelinrelapsedorrefractorylargebcelllymphomapatientsincompletemetabolicresponse AT fayadluise axicabtageneciloleucelinrelapsedorrefractorylargebcelllymphomapatientsincompletemetabolicresponse AT iyerswaminathanp axicabtageneciloleucelinrelapsedorrefractorylargebcelllymphomapatientsincompletemetabolicresponse AT hawkinsmisha axicabtageneciloleucelinrelapsedorrefractorylargebcelllymphomapatientsincompletemetabolicresponse AT flowerschristopherr axicabtageneciloleucelinrelapsedorrefractorylargebcelllymphomapatientsincompletemetabolicresponse AT ahmedsairah axicabtageneciloleucelinrelapsedorrefractorylargebcelllymphomapatientsincompletemetabolicresponse AT nastoupillorettaj axicabtageneciloleucelinrelapsedorrefractorylargebcelllymphomapatientsincompletemetabolicresponse AT kebriaeipartow axicabtageneciloleucelinrelapsedorrefractorylargebcelllymphomapatientsincompletemetabolicresponse AT shpallelizabethj axicabtageneciloleucelinrelapsedorrefractorylargebcelllymphomapatientsincompletemetabolicresponse AT neelapusattvas axicabtageneciloleucelinrelapsedorrefractorylargebcelllymphomapatientsincompletemetabolicresponse AT nietoyago axicabtageneciloleucelinrelapsedorrefractorylargebcelllymphomapatientsincompletemetabolicresponse AT stratipaolo axicabtageneciloleucelinrelapsedorrefractorylargebcelllymphomapatientsincompletemetabolicresponse |